Officials at the AFDB annual meeting stress on the necessity for investments in healthcare

COTE D’IVOIRE – Officials speaking during the Africa Development Bank meeting have emphasized that Africa’s ability to respond to future pandemics will depend on making investments in health and education.

“Ebola was a signal,” John Nkengasong, head of the Africa Centers for Disease Control and Prevention, told participants in a virtual session on healthcare held during the African Development Bank’s 2021 Annual Meetings, with regard to recent outbreaks in West Africa.

The Annual Meetings are unfolding against the backdrop of the ongoing Covid-19 pandemic, which has exposed the lack of access to primary healthcare for most Africans, as well as overreliance on imported medicines.

Nkengasong, along with other health and disease experts, urged four steps: workforce development; manufacturing capacity of diagnostics, vaccines and treatment; institution building and partnerships with the private sector, to grow Africa’s health system.

Dr. Matshidiso Moeti, the World Health Organization’s Regional Director for Africa, emphasized WHO’s partnership with the African Development Bank and regional governments.

WHO and its partners in COVAX, the worldwide initiative aimed at equitable access to Covid-19 vaccines, are also cooperating with a South African consortium including corporations, universities and the Africa CDC to set up a pioneering technology transfer hub for mRNA vaccine technology.

“This important public private partnership is an important step to building the infrastructure and human resource capacity to contribute to closing the gap in access to vaccines on the continent,” Moeti said.

African Development Bank President, Akinwumi A Adesina, underscored the Bank’s engagement with the issue.

“We must give hope to the poor and the vulnerable, by ensuring that every African, regardless of their income level, gets access to quality health care, as well as health insurance and social protection,” he said.

James Scriven, CEO of IDB Invest, the Inter-American Development Bank’s private sector institution, offered lessons from Latin America, which he described as the fastest growing region for generic pharmaceuticals.

“Now is the right time to strengthen pharma manufacturing capability in emerging countries, and support business models that can expand the reach and supply of medicines and healthcare,” he said.

Former World Bank president Jim Kim, a vice chairman and partner with Global Infrastructure Partners, said a holistic approach that would harness community workers and improved infrastructure would be crucial.

He called on the private sector to be a partner in building Africa’s healthcare defenses.

“You cannot end extreme poverty if you are neglecting the investments in health and education that are so critical to economic growth,” said Kim.

AFDB has played a critical role in enhancing healthcare services and infrastructure around the continent. Their efforts to mitigate the pandemic cannot go unnoticed, either.

Not too long ago, the bank provided $28 million in funding to the Africa Centers for Disease Control and Prevention (Africa CDC) for a Covid-19 response project.

In addition to this, AFDB has also been helping countries cope with the health emergency and the socio-economic consequences of the pandemic, notably through its Covid-19 Response Facility of up to $10 billion.

These efforts have greatly impacted the healthcare industry in the continent while saving lives and livelihoods.